CLINICAL_TRIALS
trial_result
· 2009-12-03
Clinical Trial Update: A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo [Phase 3]
Summary
A Phase 3 trial evaluating a new drug for benign prostatic hyperplasia versus placebo has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Watson Pharmaceuticals | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2009-12-03